Pfizer cancer drug takes big step toward fateful FDA decision – FierceBiotech

by lowes1 on May 17, 2011

Pfizer cancer drug takes big step toward fateful FDA decision
FierceBiotech
After wrapping up an orphan drug designation and fast track status late last year, Pfizer can now add a priority review stamp to its list of accomplishments for crizotinib, its late-stage lung cancer drug which represents one of the Big Pharma's
Pfizer's Application for Cancer Drug Accepted by FDAWall Street Journal
Pfizer Files NDA For Lung Cancer Drug Crizotinib With FDA, Japan – UpdateRTT News
Pfizer Lung Cancer Drug to Get Priority ReviewXconomy
Forbes -4-traders (press release) -CBS MoneyWatch.com (blog)
all 22 news articles »

View full post on lung cancer – Google News

Leave a Comment

Previous post:

Next post: